Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment

BACKGROUND: With declining vectorial transmission, Chagas disease predominantly affects adults nowadays. The efficacy of nifurtimox in the chronic phase in adult patients is poorly known, particularly in regions where there is no risk of reinfection. Recommendations for treatment outcome assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Yves, Chatelain, Eric, Mauris, Anne, Holst, Marylise, Miao, Qianqian, Chappuis, Francois, Ndao, Momar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574841/
https://www.ncbi.nlm.nih.gov/pubmed/23406191
http://dx.doi.org/10.1186/1471-2334-13-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574841/
https://www.ncbi.nlm.nih.gov/pubmed/23406191
http://dx.doi.org/10.1186/1471-2334-13-85

Ejemplares similares